These two pharmaceutical companies have created value for shareholders.
You'll want to follow Buffett's lead and hold on to these stocks forever.
You can take these companies' dividends straight to the bank.
Biotech-giant Amgen aims to launch a rival.
Both companies are medical device leaders.
Both companies have produced consistent revenue growth and predictable profitability.
The NYSE Composite's sideways trade since early 2021 could be a warning sign, suggesting that a shift toward dividend strategies may be prudent.
Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals....
Warren Buffett owns many stocks, but these five have solid growth potential.
If the economy falters, these stocks should hold up better than most.
